Hintergrund: Die Wirkung der Kompressionstherapie auf die lokale Mikrozirkulation und Histomorphologie ist bisher nicht ausreichend belegt. Die konfokale Laser-Scanning-Mikroskopie (KLSM) ermöglicht eine in-vivo-Untersuchung der menschlichen Haut auf zellulärer Ebene. Methode: Neunzehn Patienten mit Ulcus cruris venosum wurden folgenden Therapien zugeführt. Gruppe A: medizinische Kompressionstherapie, inaktive Wundauflage; Gruppe B: inaktive Wundauflage. Vor und 4 Wochen nach Therapiebeginn wurden folgende Parameter mittels KLSM evaluiert: zellulärer Blutfluss, Epidermisdicke, epidermale Zellgrößen, Quantität von Entzündungszellen. Ergebnisse: In Gruppe A stieg nach vierwöchiger Kompressionstherapie der zelluläre Blutfluss signifikant an, in Gruppe B nur insignifikant. Die Epidermisdicke nahm in Gruppe A mehr ab als in Gruppe B. Die epidermalen Zellen veränderten sich in beiden Gruppen nur insignifikant. Die Quantität der Entzündungszellen nahm in Gruppe A von massiv auf vereinzelt und in Gruppe B von massiv auf vermehrt ab. Conclusio: Mit der KLSM konnte die positive Wirkung der medizinischen Kompressionstherapie auf die lokale Mikrozirkulation und His-tomorphologie beim Ulcus cruris venosum nachgewiesen werden. Background: The impact of compression therapy in the most severe outcome of chronic venous insufficiency on microcirculation and his-tomorphology is widely unknown. In vivo Confocal Laser-Scanning-Microscopy (CLSM) enables insight in human skin on cellular and sub-cellular levels. In this study, the impact of compression therapy on local micromorphology in venous leg ulcer was evaluated using CLSM. Methods: Nineteen patients with chronic venous leg ulcer (ulcer size: 1 to 10 cm) were divided in two groups. Group A was treated with compression therapy and inactive wound dressing (4 m, 8 f, aged 68.4 years, BMI 26.9); Group B was treated solely with inactive wound dressing (2 m, 5 f, aged 64.2 years, BMI 28.1). Prior to start (control) and four weeks subsequently specific treatment in addition to ulcer size the following parameters were evalu- ated using CLSM (Vivascope1500®, Lucid Inc, Rochester, New York; USA): individual blood cell flow (quantity of transcapillary blood cells flow), epidermal thickness, epidermal cell size, and quantity of inflammatory cells. Results: In Group A control ulcer size was 32.4 cm2 (37.2 cm2; Group B) and decreased significantly to 8.2 cm2 (28.1 cm2; Group B, P<0.05) following four week therapy. In Group A blood cell flow was 40.04 ± 4.62/min (control) and increased up to 61.40 ± 5.16/min (P0.05). The epidermal thickness was found to be 69.10 ± 5.41 μm (control) and decreased significantly to 49.21 ± 4.60 μm in Group A. In Group B epidermal thickness was 71.48 ± 6.94 μm in controls and decreased slightly to 60.11 ± 5.16 μm. In both groups the epidermal cell size differ insignificantly (Group A 862.27 ± 42.96 μm2 vs. 839.25 ± 61.13 μm2; Group B 870.04 ± 52.43 μm2 vs. 852.73 ± 4.80 μm2, P>0.05). The quantity of inflammatory cells decreased following specific therapy in both groups from massive to less in Group A, and in Group B from massive to more. Conclusion: For the first time, CLSM demonstrated the positive impact of compression therapy in chronic venous leg ulcer on local microcirculation and histomorphology in vivo on cellular level.
27 April 2025 in European Journal of Orthopaedic Surgery & Traumatology
Background and Objectives: Polyacrylamide hydrogel (PAAG) is still underresearched, and few human studies have validated its efficacy in knee osteoarthritis (OA), particularly in advanced stages. The aim of this study was to compare the efficacy of intra-articular PAAG with that of the widely used cross-linked chondroitin sulfate/hyaluronic acid (HA/CS) combination in treating knee OA in a retrospective trial. Materials and Methods: A total of 127 patients diagnosed with grade 3 or 4 knee OA according to the Kellgren–Lawrence scale were included. The first group received an intra-articular injection of the cross-linked HA (60 mg)/CS (90 mg) combination, whereas the second group was administered 6 mL of PAAG. The outcome measures, which were assessed at baseline, 3 months, and 12 months, were knee pain severity measured with the visual analog scale (VAS), range of motion (ROM), the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale score, and the Pittsburgh Sleep Quality Index (PSQI). Results: At three months, the PAAG group demonstrated significantly lower pain and WOMAC scores than the HA/CS group, while ROM and sleep quality scores were not significantly different at either 3 or 12 months. Within-group comparisons revealed significant reductions in pain, WOMAC, and sleep scores in both groups over time, but no significant improvement in ROM was detected in either group. Conclusions: Compared with HA/CS injection, intra-articular PAAG injection significantly improved the VAS and WOMAC scores in advanced knee OA patients at three months. However, the outcomes for all the parameters were similar in the two groups at 12 months.
1 September 2025 in Journal of Clinical and Analytical Medicine
Aim We compare the results of scaphoid fracture nonunion surgeries involving vascularized bone grafting (VBG) or nonvascularized bone grafting (NVBG). Methods This study was conducted with 34 patients with scaphoid fracture nonunion. Patients were divided into two groups, including those treated with VBG (n = 17) and those treated with NVBG (n = 17). Results Union rates did not differ significantly between the VBG and NVBG groups (P = .335). There was also no significant difference in visual analogue scale (VAS) or Disabilities of the Arm, Shoulder, and Hand (DASH) scores between the two groups. However, Mayo scores were significantly higher in the VBG group compared to the NVBG group (79.41 ± 13.57 versus 64.41 ± 25.67; P = .027). Conclusion In this study, union rates in patients who underwent scaphoid fracture nonunion surgery with VBG or NVBG were compatible with the literature, and both methods were found to be reliable. There was no statistical difference between them.
27 May 2024 in Journal of Health Sciences and Medicine
Aims: The study aimed to compare in-hospital and post-discharge mortality rates and identify risk factors for patients who underwent bipolar hemiarthroplasty (BHA) or proximal femoral nailing (PFN) for hip fractures. Methods: The files of 395 patients, consisting of 129 BHA and 266 PFN patients performed between January 2017 and October 2022, were analyzed retrospectively. The demographic characteristics of the patients, in-hospital and 1-year post-discharge mortality rates, and risk factors that may have affected these mortality rates were analyzed. Results: There was no significant difference between the two groups in terms of demographic characteristics, intensive care unit (ICU) stay, American Society of Anesthesiologists (ASA) score, time to surgery, and intubation (p>0.05). The length of hospital stay and blood transfusion rates were higher in the BHA group (p0.05). The 1-year post-discharge mortality rates were higher for patients with a higher mean age, longer length of hospital stay, longer length of ICU stay, time to surgery (>48 h), for patients who underwent intubation and blood transfusion, and for those with an ASA score of 4 (p